The patent covers a new class of aromatic thermosetting copolyester — ATSP — and MXene nanocomposite materials designed for use in coating and bulk forms. The technology is directed toward potential biomedical applications where high wear resistance, mechanical strength, and biocompatibility are critical, including artificial joints, implant coatings, dental implants, spinal devices, screws, pins, plates, and other load-bearing medical components.
The patented material platform combines ATSP’s high-performance thermosetting polymer chemistry with titanium carbide MXene nanosheet reinforcement. The resulting nanocomposite was developed to provide a unique combination of low friction, high wear resistance, compressive strength, hardness, corrosion resistance, and biocompatibility in simulated body-fluid and synovial-fluid environments.
This patent represents an important milestone in ATSP Innovations’ broader strategy to develop high-performance polymer technologies for demanding applications across biomedical, energy, aerospace, industrial, and oil & gas markets.
The invention lists Ahmad Amiri, Kian Bashandeh, Andreas A. Polycarpou, and Saifur Rahman as inventors, with ATSP Innovations Inc and The Texas A&M University System listed as assignees.
“ATSP–MXene technology demonstrates how our polymer platform can be expanded beyond traditional industrial applications into next-generation biomedical materials,” said ATSP Innovations. “The issuance of this patent further validates the uniqueness of ATSP chemistry and supports our long-term vision of creating advanced material solutions for high-value, high-performance markets.”
ATSP Innovations continues to advance its materials portfolio through internal development, university collaboration, customer-driven testing, and strategic partnerships.
Note: This technology is currently a materials innovation platform and is not marketed as an FDA-cleared medical device.